Primary Treatment: Inclacumab · Has Placebo Group · Phase 3
inclacumab 30 mg/kg
Experimental Group · 1 Intervention: Inclacumab · Intervention Types: Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug
Screening: ~3 weeks
Reporting: through day 91
Who is running the clinical trial?
Global Blood TherapeuticsLead Sponsor
32 Previous Clinical Trials
4,887 Total Patients Enrolled
27 Trials studying Anemia, Sickle Cell
4,775 Patients Enrolled for Anemia, Sickle Cell
Age Any Age · All Participants · 10 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:
If you need to be hospitalized or visit an emergency room or infusion center multiple times in a short period of time, you may be able to get help from your health insurance company
Any person with a confirmed diagnosis of sickle cell disease is eligible for this study
This means that you visited a hospital, emergency department, urgent care center, outpatient clinic, or infusion center, or you had a remote contact with a healthcare provider.
Requires the use of narcotic medications that are injected into the body, as well as nonsteroidal anti-inflammatory drugs that are injected into the body, or an increase in the use of narcotic medications that are taken by mouth.
You have a VOC that is uncomplicated.
Acute splenic sequestration is a sudden enlargement of the spleen
The participant is either male or female and is at least 12 years old at the time they give informed consent.
This means that the cause of the event is unknown, but it is likely related to the blood vessels.
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.